Japanese Astronaut Suwa to Stay Aboard ISS Until Around 2027; Japan’s 8th Astronaut to Have Long-Term Stay Aboard ISS
Makoto Suwa, who will stay on the International Space Station for long-term missions, is seen in Chiyoda Ward, Tokyo, on Friday.
14:54 JST, January 10, 2026
Makoto Suwa will become the 8th Japanese astronaut to complete a long-term stay aboard the International Space Station starting around 2027, the Japan Aerospace Exploration Agency has announced.
The mission, which will be Suwa’s first in space, will mark the 15th long-term stay by a Japanese astronaut, according to JAXA.
“I want to firmly take the baton from other Japanese astronauts and pass it on to the next generation,” Suwa, 49, said at a press conference on Friday.
Suwa, a former senior disaster risk management specialist at the World Bank, was selected as a candidate astronaut in 2023. Officially certified as an astronaut in 2024, he has undergone training through NASA’s Johnson Space Center with astronauts from Europe, the United States and others, including on how to operate the robotic arm and hatches used on the ISS.
He will also undergo training on the scientific experiments that he and other astronauts will conduct aboard the ISS.
Top Articles in Science & Nature
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed
-
Record 700 Startups to Gather at SusHi Tech Tokyo in April; Event Will Center on Themes Like Artificial Intelligence and Robotics
-
iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel
-
Japan to Ban Use of Power Banks on Airplanes
-
Japan Govt Aims for 10-Fold Increase in Computing Power of Supercomputers for AI Use at Universities, Research Institutions
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

